Skip to main content
Intended for healthcare professionals

Abstract

Cardiomyopathy is a heart muscle disorder that cannot be attributed to ischemic heart disease or abnormal loading conditions such as hypertension and valvular heart disease. It can lead to the development of arrhythmia and heart failure, and is also the leading cause of sudden cardiac death in young people. Early detection is vital for delaying or preventing complications. This review discusses the four major subtypes, i.e. hypertrophic, dilated, restricted, and arrhythmogenic cardiomyopathy, which are likely to be encountered in primary care.

Get full access to this article

View all access and purchase options for this article.

References and further information

Buttner R, Burns E (2022) Hypertrophic cardiomyopathy (HCM). LITFL. ECG Library Diagnosis. Available at: https://litfl.com/hypertrophic-cardiomyopathy-hcm-ecg-library/ (accessed 13 June 2023).
Cadogan M, Burns E (2018) Epsilon Wave. LITFL Medical Blog. ECG Library Basics. Available at: https://litfl.com/epsilon-wave-ecg-library/ (accessed 13 June 2023).
Charron P, Dubourg O, Desnos M, et al. (1997) Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96(1): 214–219.
Ciarambino T, Menna G, Sansone G, et al. (2021) Cardiomyopathies: An overview. International Journal of Molecular Sciences 22(14): 7722.
Corrado D, Basso C, Judge DP (2017) Arrhythmogenic cardiomyopathy. Circulation Research 121(7): 784–802.
Corrado D, Zorzi A, Cipriani A, et al. (2021) Evolving diagnostic criteria for arrhythmogenic cardiomyopathy. Journal of the American Heart Association 10(18): e021987.
Ersbøll AS, Johansen M, Damm P, et al. (2017) Peripartum cardiomyopathy in Denmark: A retrospective, population-based study of incidence, management and outcome. European Journal of Heart Failure 19(12): 1712–1720.
European Society of Cardiology (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. European Heart Journal 35(39): 2733–2779.
Gartzonikas IK, Naka KK, Anastasakis A (2022) Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy. Hellenic Journal of Cardiology 70: 65–74.
Gowda SN, Ali H-J, Hussain I (2022) Overview of restrictive cardiomyopathies. Methodist DeBakey Cardiovascular Journal 18(2): 4–16.
Guttmann OP, Rahman MS, O’Mahony C, et al. (2013) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: Systematic review. Heart 100(6): 465–472.
Hänselmann A, Veltmann C, Bauersachs J, et al. (2020) Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz 45(3): 212–220.
Iavarone M, Monda E, Vritz O, et al. (2022) Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy. Archives of Cardiovascular Diseases 115(10): 529–537.
Japp AG, Gulati A, Cook SA, et al. (2016) The diagnosis and evaluation of dilated cardiomyopathy. Journal of the American College of Cardiology 67(25): 2996–3010.
Jefferies JL, Towbin JA (2010) Dilated cardiomyopathy. Lancet (London, England) 375(9716). England: 752–762.
Kühl U, Pauschinger M, Schwimmbeck PL, et al. (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22): 2793–2798.
Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circulation Research 121(7): 749–770.
Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. The Lancet 381(9862): 242–255.
Maron M, Rowin E, Spirito P, et al. (2022) Differing strategies for sudden death prevention in hypertrophic cardiomyopathy. Heart: heartjnl-2020-316693.
McNally EM, Mestroni L (2017) Dilated cardiomyopathy. Circulation Research 121(7): 731–748.
Mestroni L, Maisch B, McKenna WJ, et al. (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. European Heart Journal 20(2): 93–102.
Muchtar E, Blauwet LA, Gertz MA (2017) Restrictive cardiomyopathy. Circulation Research 121(7): 819–837.
Nakatani T (2009) Heart transplantation. Circulation Journal: Official Journal of the Japanese Circulation Society 73 Suppl A: A55–60.
NICE (2018) Chronic heart failure in adults: Diagnosis and management. Available at: www.nice.org.uk/guidance/ng106 (accessed 13 June 2023).
Ommen SR, Mital S, Burke MA, et al. (2020) 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: Executive Summary. Circulation 142(25): e533–e557.
Piano MR, Phillips SA (2014) Alcoholic cardiomyopathy: Pathophysiologic insights. Cardiovascular Toxicology 14(4): 291–308.
Rai TS, Ahmad S, Ahluwalia TS, et al. (2009) Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy. Molecular and Cellular Biochemistry 331(1-2): 187–192.
Rapezzi C, Aimo A, Barison A, et al. (2022) Restrictive cardiomyopathy: Definition and diagnosis. European Heart Journal 43(45): 4679–4693.
RCGP. Clinical topic guide: Cardiovascular health. Available at: www.rcgp.org.uk/mrcgp-exams/gp-curriculum/clinical-topic-guides#cardiovascular (accessed 13 June 2023).
Rodriguez Ziccardi M, Siddique MS (2020) Peripartum cardiomyopathy. Available at: www.ncbi.nlm.nih.gov/books/NBK482185 (accessed 13 June 2023).
Schultheiss H-P, Fairweather D, Caforio ALP, et al. (2019) Dilated cardiomyopathy. Nature Reviews Disease Primers 5(1): 32.
Siontis KC, Geske JB, Ong K, et al. (2014) Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 3(3): e001002.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Pages: 12 - 19
Article first published online: October 28, 2023
Issue published: January 2024

Rights and permissions

© The Author(s) 2023.
Request permissions for this article.

Authors

Affiliations

Metrics and citations

Metrics

Journals metrics

This article was published in InnovAiT: Education and inspiration for general practice.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 280

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 0

Crossref: 0

There are no citing articles to show.

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

RCGP members can access this journal content using society membership credentials.

RCGP members can access this journal content using society membership credentials.


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text